Swiss Life Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-14,918
Closed -$2.64M 547
2020
Q1
$2.64M Buy
14,918
+11,348
+318% +$2.14M 0.05% 238
2019
Q4
$683K Sell
3,570
-1,490
-29% -$269K 0.01% 416
2019
Q3
$852K Buy
5,060
+1,556
+44% +$254K 0.01% 406
2019
Q2
$585K Sell
3,504
-1,490
-30% -$206K 0.01% 444
2019
Q1
$731K Buy
+4,994
New +$724K 0.01% 390
2018
Q4
Sell
-6,913
Closed -$1.32M 512
2018
Q3
$1.32M Sell
6,913
-2,499
-27% -$459K 0.02% 370
2018
Q2
$1.57M Buy
9,412
+3,921
+71% +$629K 0.02% 343
2018
Q1
$924K Buy
5,491
+2,810
+105% +$471K 0.02% 382
2017
Q4
$439K Sell
2,681
-4,652
-63% -$835K 0.01% 404
2017
Q3
$1.5M Buy
+7,333
New +$1.71M 0.04% 241

Other funds holding AGN

Swiss Life Asset Management's AGN Position: Q2 2020 in Review

Swiss Life Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,918 shares — an estimated $2.64M sold.

Swiss Life Asset Management first reported a position in AGN in Q3 2017 and held it in 10 quarters. The position peaked at $2.64M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Swiss Life Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Swiss Life Asset Management sold 14,918 Allergan plc shares in Q2 2020, an estimated $2.64M.
  • Swiss Life Asset Management first reported a position in Allergan plc in Q3 2017 and held it in 10 quarters.
  • Swiss Life Asset Management's Allergan plc position peaked at $2.64M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Swiss Life Asset Management's 13F filing for Q2 2020, filed 29 Dec 2025.